Page 17 - Risk quantification and modification in older patients with colorectal cancer

References
1. Netherlands Cancer Registry (NKR). Retrieved from www.cijfersoverkanker.nl: [Accessed 01 June 2018].
2. Arnold M, Sierra MS, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global patterns and trends in colorectal cancer incidence and mortality. Gut. 2017;66(4):683-91.
3. Labianca R, Nordlinger B, Beretta GD, Mosconi S, Mandala M, Cervantes A, et al. Early colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology. 2013;24 Suppl 6(suppl_6):vi64-72.
4. Dekker JW, Gooiker GA, Bastiaannet E, van den Broek CB, van der Geest LG, van de Velde CJ, et al. Cause of death the first year after curative colorectal cancer surgery; a prolonged impact of the surgery in elderly colorectal cancer patients. European Journal of Surgical Oncology. 2014;40(11):1481-7.
5. Fagard K, Leonard S, Deschodt M, Devriendt E, Wolthuis A, Prenen H, et al. The impact of frailty on postoperative outcomes in individuals aged 65 and over undergoing elective surgery for colorectal cancer: A systematic review. Journal of Geriatric Oncology. 2016;7(6):479-91.
6. Gooiker GA, Dekker JW, Bastiaannet E, van der Geest LG, Merkus JW, van de Velde CJ, et al. Risk factors for excess mortality in the first year after curative surgery for colorectal cancer. Annals of Surgical Oncology. 2012;19(8):2428-34.
7. Dekker JW, van den Broek CB, Bastiaannet E, van de Geest LG, Tollenaar RA, Liefers GJ. Importance of the first postoperative year in the prognosis of elderly colorectal cancer patients. Annals of Surgical Oncology. 2011;18(6):1533-9.
8. Hamaker ME, Prins MC, Schiphorst AH, van Tuyl SA, Pronk A, van den Bos F. Long-term changes in physical capacity after colorectal cancer treatment. Journal of Geriatric Oncology. 2015;6(2):153-64.
9. Brown SR, Mathew R, Keding A, Marshall HC, Brown JM, Jayne DG. The impact of postoperative complications on long-term quality of life after curative colorectal cancer surgery. Annals of Surgery. 2014;259(5):916-23.
10. Di Cristofaro L, Ruffolo C, Pinto E, Massa M, Antoniutti M, Cagol M, et al. Complications after surgery for colorectal cancer affect quality of life and surgeon-patient relationship. Colorectal Disease. 2014;16(12):O407-19.
11. Stucky CC, Pockaj BA, Novotny PJ, Sloan JA, Sargent DJ, O’Connell MJ, et al. Long-term follow-up and individual item analysis of quality of life assessments related to laparoscopic-assisted colectomy in the COST trial 93-46-53 (INT 0146). Annals of Surgical Oncology. 2011;18(9):2422-31.
12. Hamaker ME, Stauder R, van Munster BC. Exclusion of older patients from ongoing clinical trials for hematological malignancies: an evaluation of the National Institutes of Health Clinical Trial Registry. Oncologist. 2014;19(10):1069-75.
13. Schulkes KJ, Nguyen C, van den Bos F, van Elden LJ, Hamaker ME. Selection of Patients in Ongoing Clinical Trials on Lung Cancer. Lung. 2016.
14. Claassen YHM, Vermeer NCA, Iversen LH, van Eycken E, Guren MG, Mroczkowski P, et al. Treatment and survival of rectal cancer patients over the age of 80 years: a EURECCA international comparison. British Journal of Cancer. 2018;119(4):517-22.
15. Vermeer NCA, Claassen YHM, Derks MGM, Iversen LH, van Eycken E, Guren MG, et al. Treatment and Survival of Patients with Colon Cancer Aged 80 Years and Older: A EURECCA International Comparison. Oncologist. 2018;23(8):982-90.
16. Kim SW, Han HS, Jung HW, Kim KI, Hwang DW, Kang SB, et al. Multidimensional frailty score for the prediction of postoperative mortality risk. JAMA Surg. 2014;149(7):633-40.
17. Kwag S-J, Kim J-G, Kang W-K, Lee J-K, Oh S-T. The nutritional risk is a independent factor for postoperative morbidity in surgery for colorectal cancer. Annals of Surgical Treatment and Research. 2014;86(4):206-11.
18. Turner JP, Shakib S, Singhal N, Hogan-Doran J, Prowse R, Johns S, et al. Prevalence and factors associated with polypharmacy in older people with cancer. Supportive Care in Cancer. 2014;22(7):1727-34.
19. Maggiore RJ, Dale W, Gross CP, Feng T, Tew WP, Mohile SG, et al. Polypharmacy and Potentially Inappropriate Medication Use in Older Adults with Cancer Undergoing Chemotherapy: Effect on Chemotherapy-Related Toxicity and Hospitalization During Treatment. 2014;62(8):1505-12.
20. Nightingale G, Hajjar E, Guo K, Komura S, Urnoski E, Sendecki J, et al. A pharmacist-led medication assessment used to determine a more precise estimation of the prevalence of complementary and alternative medication (CAM) use among ambulatory senior adults with cancer. Journal of Geriatric Oncology. 2015;6(5):411-7.
Introduction and thesis outline
15
1